tradingkey.logo

Tempus AI Inc

TEM
查看詳細走勢圖
69.409USD
-1.201-1.70%
交易中 美東報價延遲15分鐘
12.34B總市值
虧損本益比TTM

Tempus AI Inc

69.409
-1.201-1.70%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.70%

5天

-9.46%

1月

+1.36%

6月

-2.63%

今年開始到現在

+105.59%

1年

+69.29%

查看詳細走勢圖

TradingKey Tempus AI Inc股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Tempus AI Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名88/404位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價91.79。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Tempus AI Inc評分

相關信息

行業排名
88 / 404
全市場排名
202 / 4592
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 15 分析師
買入
評級
91.785
目標均價
+19.14%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Tempus AI Inc亮點

亮點風險
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
業績高增長
公司營業收入穩步增長,連續3年增長116.24%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入693.40M美元
估值低估
公司最新PE估值-242.90,處於3年歷史低位
機構減倉
最新機構持股75.72M股,環比減少5.26%
羅恩·巴倫持倉
明星投資者羅恩·巴倫持倉,最新持倉263.25K股

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Tempus AI Inc簡介

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
公司代碼TEM
公司Tempus AI Inc
CEOLefkofsky (Eric P)
網址https://investors.tempus.com/

常見問題

Tempus AI Inc(TEM)的當前股價是多少?

Tempus AI Inc(TEM)的當前股價是 69.409。

Tempus AI Inc 的股票代碼是什麼?

Tempus AI Inc的股票代碼是TEM。

Tempus AI Inc股票的52週最高點是多少?

Tempus AI Inc股票的52週最高點是104.320。

Tempus AI Inc股票的52週最低點是多少?

Tempus AI Inc股票的52週最低點是31.360。

Tempus AI Inc的市值是多少?

Tempus AI Inc的市值是12.34B。

Tempus AI Inc的淨利潤是多少?

Tempus AI Inc的淨利潤為-746.33M。

現在Tempus AI Inc(TEM)的股票是買入、持有還是賣出?

根據分析師評級,Tempus AI Inc(TEM)的總體評級為買入,目標價格為91.785。

Tempus AI Inc(TEM)股票的每股收益(EPS TTM)是多少

Tempus AI Inc(TEM)股票的每股收益(EPS TTM)是-0.291。
KeyAI